← Addex Therapeutics Ltd. ADXN
Market Price
$6.06
Market Cap
$7.34M
P/E Ratio
N/A
Revenue (FY 2025)
↓-92.6% YoY
$29.97K
3-Yr CAGR: -72.4%
Net Income
↓-39.4% YoY
-$6.84M
Net Margin: -22,829.9%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
-143.6%
ROA: -107.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ADXN)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | — | — | — | $-3.3M | — | — | — | — | — | — |
| FY 2018 | $6.0M | — | $5.9M | $-1.6M | +49.9% | — | — | — | — | — |
| FY 2019 | $2.8M | -54.3% | $2.7M | $-14.8M | -798.6% | — | — | — | — | — |
| FY 2020 | $3.6M | +30.8% | $3.6M | $-12.9M | +13.0% | — | — | — | — | — |
| FY 2021 | $2.9M | -19.3% | $2.9M | $-15.4M | -19.4% | — | — | — | — | — |
| FY 2022 | $1.4M | -51.2% | $1.4M | $-20.8M | -35.5% | — | — | — | — | — |
| FY 2023 | $1.6M | +13.4% | $1.6M | $-10.6M | +49.3% | — | — | — | — | — |
| FY 2024 | $0.4M | -74.9% | $0.4M | $-4.9M | +53.5% | — | — | — | — | — |
| FY 2025 | $0.0M | -92.6% | $0.0M | $-6.8M | -39.4% | — | — | — | — | — |
Valuation
Market Price
$6.06
Market Cap
$7.34M
Enterprise Value
$5.76M
P/E Ratio
N/A
P/B Ratio
1.61
FCF Yield
N/A
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
91.92%
Operating Margin
-9,390.76%
Net Margin
-22,829.93%
Return on Equity (ROE)
-143.55%
Return on Assets (ROA)
-107.52%
Asset Turnover
0.00x
Revenue 3-Yr CAGR
-72.38%
Financial Health & Liquidity
Current Ratio
4.21
Cash Ratio
4.11
Debt / Equity
0.013
Debt / Assets
0.010
Cash & Equivalents
$1.64M
Total Debt
$61.70K
Book Value / Share
$3.77
Cash Flow Efficiency
Operating Cash Flow
N/A
Capital Expenditures (CapEx)
N/A
Free Cash Flow
N/A
OCF / Revenue
N/A
FCF / Revenue
N/A
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$3.77
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$6.36M
Total Liabilities
$1.60M
Stockholders' Equity
$4.77M
Current Assets
$1.68M
Current Liabilities
$398.62K